Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review
about
Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaComparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study.Clinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon.Malaria: an update on current chemotherapy.Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens.In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trialSustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient complianceBreakdown of phosphatidylserine asymmetry following treatment of erythrocytes with lumefantrine.Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania.Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery.Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence.
P2860
Q26820807-CD48D289-854C-46DB-B5A0-F42E659CDAA2Q33686633-CA8B049C-C92A-4DDD-AF93-ABA1E9F3EE25Q33687284-3575889C-8ECE-421D-81F3-84150A915AA4Q34433106-93C4B183-73EF-49BF-BBFC-DEA7954B2F10Q35097323-CD881877-0E69-4256-BE6A-D2E2C16E5128Q36836576-40EC98F9-4777-4C89-A270-C98701EEC757Q37270727-91048129-F4BE-484F-9A3D-DE917145EFF2Q37469233-7988C0ED-4AF0-4D0A-A909-F66769203C99Q37617809-EA21DF32-9634-467E-AC6E-8BE57A321A68Q39941785-B84A43DC-541E-40C9-AA7F-E77DFC782EA7Q47407497-FE59BE43-09B8-4F26-8451-CA7E194E9676Q47865259-204D591C-4068-471A-A526-016B8C26A93CQ55453605-34396FAE-4967-44CD-B82D-B9CB77CBD887
P2860
Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparative safety of artemeth ...... children: a systematic review
@ast
Comparative safety of artemeth ...... children: a systematic review
@en
type
label
Comparative safety of artemeth ...... children: a systematic review
@ast
Comparative safety of artemeth ...... children: a systematic review
@en
prefLabel
Comparative safety of artemeth ...... children: a systematic review
@ast
Comparative safety of artemeth ...... children: a systematic review
@en
P2860
P921
P356
P1433
P1476
Comparative safety of artemeth ...... children: a systematic review
@en
P2093
Oluwaseun Egunsola
P2860
P2888
P356
10.1186/1475-2875-12-385
P577
2013-11-01T00:00:00Z
P5875
P6179
1030934775